Reference : Panoplies des therapies ciblees par anticorps monoclonaux en dermatologie. Actualite et ...
Scientific journals : Article
Human health sciences : Dermatology
http://hdl.handle.net/2268/12642
Panoplies des therapies ciblees par anticorps monoclonaux en dermatologie. Actualite et prospectives.
French
[en] A range of targeted treatments using monoclonal antibodies in dermatology. Current and future practice
Pierard, Claudine mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Quatresooz, Pascale mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Paquet, Philippe mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
Nikkels, Arjen mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatologie >]
Pierard, Gérald mailto [Centre Hospitalier Universitaire de Liège - CHU > > Dermatopathologie >]
2009
Revue Médicale de Liège
Hopital de Baviere
64
5-6
334-8
Yes (verified by ORBi)
National
0370-629X
Liège
Belgique
[en] Antibodies, Monoclonal/therapeutic use ; Dermatologic Agents/therapeutic use ; Humans ; Skin Diseases/drug therapy
[en] Targeted therapies are focused on one or a few molecules particularly involved in specific diseases. Some inflammatory dermatoses and cutaneous neoplasia potentially benefit from these approaches. Nine monoclonal antibodies of interest in dermatology are presented according to the disorders where they have proven their efficacy. Biotherapies extend beyond monoclonal antibodies. A given effect, such as TNF-alpha antagonism, is indeed obtained by distinct drug classes. The interindividual differences in the therapeutic responses remain unpredictable, and there is no criteria of selection of patients who could benefit the most from these targeted medications.
http://hdl.handle.net/2268/12642

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
PANOPLIE.pdfPublisher postprint336.45 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.